PLC
This article was originally published in The Gray Sheet
Executive Summary
Raises $3.7 mil. from the exercise of "essentially all" of its 796,400 outstanding common stock purchase warrants, which were called April 7 for redemption and which expired May 13. Proceeds have "been infused" into the firm's working capital and will be used for clinicals and regulatory approval. The Milford, Massachusetts-based producer of medical laser systems is in Phase II clinicals of its Heart Laser for transmyocardial revascularization.